BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 157237)

  • 1. Sanfilippo B syndrome (MPS III B): mild and severe forms within the same sibship.
    Andria G; Di Natale P; Del Giudice E; Strisciuglio P; Murino P
    Clin Genet; 1979 Jun; 15(6):500-4. PubMed ID: 157237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.
    Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N
    Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of heparan sulfate induced by immunostimulation in a patient with mucopolysaccharidosis IIIA.
    Zerial M; Florio C; Dolzani L; Moro L; Romeo D
    Biochem Med; 1984 Apr; 31(2):228-35. PubMed ID: 6232924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sanfilippo B syndrome (MPS III B): altered residual alpha-N-acetylglucosaminidase activity in an unusual sibship.
    Di Natale P; Murino P; Pontarelli G; Salvatore D; Andria G
    Clin Chim Acta; 1982 Jul; 122(2):135-43. PubMed ID: 6809360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanfilippo B disease in two related sibships. Biochemical studies in patients, parents and sibs.
    Liem KO; Giesberts MA; van de Kamp JJ; van Pelt JF; Hooghwinkel GJ
    Clin Genet; 1976 Nov; 10(5):273-8. PubMed ID: 825332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionation and characterization of urinary heparan sulfate excreted by patients with Sanfilippo syndrome.
    Kimura A; Hayashi S; Koseki M; Kochi H; Tsurumi K
    Tohoku J Exp Med; 1984 Nov; 144(3):227-36. PubMed ID: 6240800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new cases.
    Coppa GV; Giorgi PL; Felici L; Gabrielli O; Donti E; Bernasconi S; Kresse H; Paschke E; Mastropaolo C
    Eur J Pediatr; 1983 Apr; 140(2):130-3. PubMed ID: 6411475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The laboratory diagnosis of Sanfilippo disease.
    Whiteman P; Young E
    Clin Chim Acta; 1977 Apr; 76(1):139-47. PubMed ID: 404099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanfilippo A syndrome in the fetus.
    Greenwood RS; Hillman RE; Alcala H; Sly WS
    Clin Genet; 1978 Mar; 13(3):241-50. PubMed ID: 147760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sanfilippo B syndrome (MPS III B): case report with analysis of CSF mucopolysaccharides and conjunctival biopsy.
    Federico A; Capece G; Cecio A; D'Auria N; Di Iorio G; Ronsisvalle L; Di Natale P
    J Neurol; 1981; 225(2):77-83. PubMed ID: 6164767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective heparan sulfate metabolism in the Sanfilippo syndrome and assay of this defect in the assessment of the mucopolysaccharidoses patient.
    Gordon BA; Feleki V; Budreau CH; Tyler L
    Clin Biochem; 1975 Jun; 8(3):184-93. PubMed ID: 238759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal tests for Sanfilippo disease type B in four pregnancies.
    Mossman J; Young EP; Patrick AD; Fensom AH; Ellis M; Benson PF; Der Kaloustian VM
    Prenat Diagn; 1983 Oct; 3(4):347-50. PubMed ID: 6419220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study of the siblings of Sanfilippo B syndrome (MPS III B)].
    Tamagawa K; Nakajima S; Terauchi A; Koide H; Morimatsu Y; Nishiya O; Mimura A
    No To Hattatsu; 1983; 15(1):57-66. PubMed ID: 6401424
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C).
    van de Kamp JJ; Niermeijer MF; von Figura K; Giesberts MA
    Clin Genet; 1981 Aug; 20(2):152-60. PubMed ID: 6796310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular size difference of urinary heparan sulfates from normal individuals and genetic mucopolysaccharidoses.
    Taniguchi N; Miyawaki T; Moriya N; Okuda N
    Clin Chim Acta; 1975 May; 60(3):363-9. PubMed ID: 124636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sanfilippo B syndrome. A case report.
    Shimamura K; Hakozaki H; Takahashi K; Kimura A; Fujino J
    Acta Pathol Jpn; 1976 Nov; 26(6):739-64. PubMed ID: 827922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease.
    de Ruijter J; Ijlst L; Kulik W; van Lenthe H; Wagemans T; van Vlies N; Wijburg FA
    J Inherit Metab Dis; 2013 Mar; 36(2):271-9. PubMed ID: 22968582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical definition of the mucopolysaccharidoses.
    Constantopoulos G; Dekaban AS
    Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sanfilippo type C syndrome in two sisters.
    Uvebrant P
    Acta Paediatr Scand; 1985 Jan; 74(1):137-9. PubMed ID: 3920864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.